• 3762793534@qq.com
  • 武汉东湖新技术开发区光谷三路777号自贸生物创新港B区(生物医药平台检验研发楼)Q306-307
/static/upload/image/20240719/1721360457956334.png

新品研发

Recilisib sodium(防辐射产品)

CAS NO:922139-31-9

纯度:98%(HPLC)

外观:白色至灰白色粉末

QQ:3762793534

Wechat:18202741975

产品详情


中文名称:Recilisib sodium,4-[(E)-2-[(4-chlorophenyl)methylsulfonyl]ethenyl]benzoate

英文名称:sodium,4-[(E)-2-[(4-chlorophenyl)methylsulfonyl]ethenyl]benzoate

英文别名:Ex-Rad;UNII-1068SXU525;

CAS号:922139-31-9

分子式:C16H12ClNaO4S

分子量:358.77200

精确质量:358.00400

PSA:82.65000

LOGP:3.37000

 

 

Ex-Rad (or Ex-RAD), also known by the code name ON 01210.Na, or recilisib sodium (INN, USAN) is a drug developed by Onconova Therapeutics and the U.S. Department of Defense. This newly developed compound is said to be a potent radiation protection agent. Chemically, it is the sodium salt of 4-carboxystyryl-4-chlorobenzylsulfone.